Bayesian cost-effectiveness analysis. An example using the GUSTO trial.

scientific article published in January 2001

Bayesian cost-effectiveness analysis. An example using the GUSTO trial. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S0266462301104083
P698PubMed publication ID11329847

P2093author name stringFryback DG
Chinnis JO Jr
Ulvila JW
P433issue1
P304page(s)83-97
P577publication date2001-01-01
P1433published inInternational Journal of Technology Assessment in Health CareQ15750683
P1476titleBayesian cost-effectiveness analysis. An example using the GUSTO trial.
P478volume17

Reverse relations

cites work (P2860)
Q51984621A Bayesian approach to net health benefits: an illustration and application to modeling HIV prevention.
Q44836122A Bayesian model averaging approach for cost-effectiveness analyses
Q33672350A cost minimisation analysis in teledermatology: model-based approach
Q40285528An iterative Bayesian approach to health technology assessment: application to a policy of preoperative optimization for patients undergoing major elective surgery
Q81967940Assessing the value of a future study
Q44519601Bayesian cost-effectiveness analysis with two measures of effectiveness: the cost-effectiveness acceptability plane
Q36381197Bayesian methods for evidence synthesis in cost-effectiveness analysis
Q33859002Bayesian variable selection in cost-effectiveness analysis
Q45424160Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis
Q46115086Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women
Q87855255Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes
Q38851169Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation
Q41177877Cost-effectiveness of intracoronary flow velocity measurements and myocardial perfusion scintigraphy for management of intermediate coronary lesions
Q40301879Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia
Q35040678Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
Q33511681Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessments
Q36453628Health and economic effects from linking bedside and outpatient tobacco cessation services for hospitalized smokers in two large hospitals: study protocol for a randomized controlled trial
Q52010751Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework.
Q36886256The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis

Search more.